The Effect of Non-invasive Hemoglobin Measurement in Hip Surgeries
- Conditions
- Hemodynamic InstabilityBleedingHemorrhage
- Interventions
- Device: non-invasive hemoglobin (SpHb)
- Registration Number
- NCT04785274
- Lead Sponsor
- Bulent Ecevit University
- Brief Summary
Bleeding is one of the most important causes of mortality and morbidity in patients.
Hb levels are the most prevalently utilized monitoring parameter in hemorrhagic patients in the hemodynamic sense. Hemoglobin determination is studied at laboratories along with blood gasses or complete blood analysis. Recently, non-invasive techniques where measurement is made from the fingertips have been offered for use. One of these techniques is non-invasive hemoglobin (SpHb) measurement. SpHb is used as a trend monitor. Based on the severity of bleeding, the compensatory mechanisms of patients may be disrupted. This situation may lead to lower levels of toleration of anemia during bleeding. The relationship between blood transfusion and mortality is under debate.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
- 18-60 years old
- General anesthesia undergoing hip surgery
- American society of anesthesiology (ASA) scores I-II-III
- Receiving inotropic support
- Uncontrolled diabetes
- Arrhythmia
- Hypothermia
- Hyperbilirubinemia
- Jaundice
- Dark skin pigmentation
- Without voluntary consent
- Hypovolemia,
- hypotension,
- sepsis,
- blood diseases
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description SpHb non-invasive hemoglobin (SpHb) - Control non-invasive hemoglobin (SpHb) -
- Primary Outcome Measures
Name Time Method Hemodynamic Stability during the surgery to compare blood transfusion decisions made with SpHb measurement values and with conventional methods in patient who would receive hip surgery.
- Secondary Outcome Measures
Name Time Method Mortality until 3 months after surgery to compare the effects of transfusion results on mortality.
Trial Locations
- Locations (1)
Zonguldak Bulent Ecevit University Medicine Faculty
🇹🇷Zonguldak, Turkey